26 Jan 2026
Europe adopted biosimilars early with clear rules and high adoption. The US lagged due to patents and regulatory hurdles-but is now catching up fast. Here's how the two markets differ and why it matters for patients and costs.
5 Jan 2026
Biosimilars offer major cost savings and proven safety, but patient hesitation remains high due to misinformation and lack of transparency. Learn how to understand biosimilars, address concerns, and make informed decisions with your doctor.
